Immunosuppression Prevalence Doubled, Linked to Medication Use and COVID: Experts
In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. The estimate was 2.7 percent in 2013.
Between 2013 and 2021, rates of immunosuppression in adults have doubled, according to estimates from a Journal of the American Medical Association (JAMA) research letter.
The researchers estimated immunosuppression prevalence by analyzing National Health Interview Survey (NHIS) results.
Specifically, the authors analyzed responses to five questions. Over 29,000 individuals were asked if they had a health condition or were taking medication or treatments that would weaken their immune system. They were also asked if they had cancer or malignancy, the type of cancer, and their age at the time of cancer diagnosis.
Why the Rise in Immunosuppression?
“Given the documented increase in immunosuppression, studies are needed to understand the causes for this increase,” the authors wrote. However, they mentioned that the rise in self-reported immunosuppression may be due to increased use of immunosuppressive medications.
The use of adalimumab, a drug used to treat autoimmune conditions, has increased 3.5-fold between 2014 and 2021.
Immunosuppression carries significant risks, “including an increased susceptibility to infections, potential organ rejection, side effects of immunosuppressant drugs, elevated cancer risk, and pregnancy-related concerns,” Mohammad Razzaque, professor of pathology at the Lake Erie College of Osteopathic Medicine, told The Epoch Times.
Immunosuppression occurs naturally with age, but it can also occur due to the individual being on various immunosuppressive therapies. People undergoing such therapies include organ transplant patients and those with autoimmune diseases or cancer.
Dr. William Schaffner, a professor of medicine and preventative medicine at the Vanderbilt University School of Medicine, reasoned that the rising prevalence could signify progress in science and health.
“There are more and more people being kept alive and are being treated with immunosuppressant agents in the United States, and that treatment is extending life, which means that the proportion of the population that is immunosuppressed is increasing,” Dr. Schaffner said.
NHIS’ most recent survey in 2022 estimated that a slight decrease of 9.6 percent of adults had cancer.
The COVID-19 pandemic may have also made individuals more aware of their immune health and whether they are immunosuppressed, the research letter authors added.
COVID-19 and Immunosuppression
Studies have shown that the COVID-19 virus can disrupt the function and order of the immune system, leading to immune dysfunction and possible immunodeficiency.
The COVID-19 pandemic may have been particularly challenging to those already immunocompromised.
Other researchers and physicians argue that the COVID-19 vaccines may also contribute to immunosuppression and deficiencies, though some research has opposite findings.
Dr. Schaffner said whether increased infections linked to repeat vaccinations are a sign of general immunosuppression is debatable.
“It’s a very debatable issue,” he said, adding that even if there is an increased risk of COVID-19 infection linked to repeat vaccination, there does not seem to be “serious evidence” indicating a “general suppression of the immune system.”
Bifidobacteria are essential for boosting intestinal immunity. Dr. Hazan’s earlier work showed that people with reduced Bifidobacteria in the gut were at risk of severe COVID-19 infections, and therapeutics that replenished the Bifidobacteria, such as vitamins C and D and ivermectin improved patient survival rates.
“The pandemic appears to have influenced what the public thinks about their immune system. There has been a big jump in perceived weakness in the immune system. More research is needed to determine if either SARS-CoV-2 infection or COVID-19 vaccine indeed has impaired human immunity according to these perceptions,” Dr. Peter McCullough, renowned cardiologist and internist, told The Epoch Times.
This article has been archived for your research. The original version from Epoch Times can be found here.